Detecting oral cancer in its earliest stages can save the lives of the nearly 40,500 people diagnosed annually. But early detection has been difficult. Researchers discovered a biomarker, called human beta defensin-3, which may serve as an early warning. The defensin is present in all oral cancers and associated with the early stages of oral cancer.